DarioHealth Adds Hypertension Care, Triples Revenue Opportunity with Top-5 Insurer
DRIO•DarioHealth extended its digital health agreement with a top-five U.S. insurer, adding its AI-driven hypertension solution to an existing behavioral health deployment. The added cardiometabolic care could triple the addressable revenue opportunity under this customer, with revenue contributions starting in 2026 and growing in 2027.
1. Agreement Extension and Hypertension Addition
DarioHealth extended its agreement with a top-five U.S. health insurer, expanding beyond its initial behavioral health deployment by adding an AI-driven hypertension solution covering pre-hypertension to Stage 2 cases. Eligible members will now have integrated access across the full blood pressure continuum for earlier intervention.
2. Revenue Outlook and Timeline
The rollout of DarioHealth's cardiometabolic care significantly increases the addressable population and could triple the revenue opportunity under this insurer relationship. Revenue from the expanded program is expected to begin in 2026, with larger contributions anticipated in 2027 and beyond.
3. Validation of Multi-Condition Platform
This expansion marks the third health plan to broaden its deployment beyond a single condition, reinforcing DarioHealth's land-and-expand strategy and its multi-condition platform. With 12 health plan customers and six chronic condition solutions—including new provider-led care delivery capabilities—the platform aims to deepen payer relationships and drive long-term growth.
